Advertisement

Index by Author

April 1998; 47 (4)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Aganna, E

    • Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes April 1998 47:688-690; doi:10.2337/diabetes.47.4.688

  2. Aguilar-Bryan, L

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

  3. Almind, K

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

  4. Andrikopoulos, S

    • Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes April 1998 47:640-645; doi:10.2337/diabetes.47.4.640

  5. Araki, E

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

  6. Argyropoulos, G

    • Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects. Diabetes April 1998 47:685-687; doi:10.2337/diabetes.47.4.685

  7. Asberry, P J

    • Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes April 1998 47:640-645; doi:10.2337/diabetes.47.4.640

  8. Atkinson, M A

    • The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes April 1998 47:566-569; doi:10.2337/diabetes.47.4.566

B

  1. Babazono, T

    • Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes April 1998 47:668-676; doi:10.2337/diabetes.47.4.668

  2. Baldoncini, R

    • Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes April 1998 47:660-667; doi:10.2337/diabetes.47.4.660

  3. Baskin, D G

    • Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes April 1998 47:538-543; doi:10.2337/diabetes.47.4.538

  4. Beger, C

    • Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation. Diabetes April 1998 47:559-565; doi:10.2337/diabetes.47.4.559

  5. Bellini, C

    • Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes April 1998 47:660-667; doi:10.2337/diabetes.47.4.660

  6. Beshay, E

    • The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice. Diabetes April 1998 47:570-575; doi:10.2337/diabetes.47.4.570

  7. Boucher, B J

    • Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes April 1998 47:688-690; doi:10.2337/diabetes.47.4.688

  8. Boyadjian, R

    • Physiological insulinemia acutely modulates plasma leptin. Diabetes April 1998 47:544-549; doi:10.2337/diabetes.47.4.544

  9. Boyko, E J

    • Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes April 1998 47:640-645; doi:10.2337/diabetes.47.4.640

  10. Brown, A M

    • Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects. Diabetes April 1998 47:685-687; doi:10.2337/diabetes.47.4.685

  11. Brubaker, P L

    • Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes April 1998 47:632-639; doi:10.2337/diabetes.47.4.632

  12. Bryan, J

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

  13. Bursell, S E

    • Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats. Diabetes April 1998 47:653-659; doi:10.2337/diabetes.47.4.653

C

  1. Castillo, G M

    • Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes April 1998 47:612-620; doi:10.2337/diabetes.47.4.612

  2. Cherrington, A D

    • Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes April 1998 47:523-529; doi:10.2337/diabetes.47.4.523

  3. Chu, C A

    • Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes April 1998 47:523-529; doi:10.2337/diabetes.47.4.523

  4. Cirulli, V

    • Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation. Diabetes April 1998 47:559-565; doi:10.2337/diabetes.47.4.559

  5. Clausen, J O

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

  6. Clermont, A C

    • Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats. Diabetes April 1998 47:653-659; doi:10.2337/diabetes.47.4.653

  7. Cook, S M

    • Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes April 1998 47:632-639; doi:10.2337/diabetes.47.4.632

  8. Corbett, J A

    • Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes April 1998 47:583-591; doi:10.2337/diabetes.47.4.583

  9. Cummings, J A

    • Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes April 1998 47:612-620; doi:10.2337/diabetes.47.4.612

D

  1. De Angelis, C

    • Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes April 1998 47:660-667; doi:10.2337/diabetes.47.4.660

  2. Desideri, G

    • Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes April 1998 47:660-667; doi:10.2337/diabetes.47.4.660

  3. Dhir, V

    • Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats. Diabetes April 1998 47:653-659; doi:10.2337/diabetes.47.4.653

  4. Dittler, J

    • GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes April 1998 47:592-597; doi:10.2337/diabetes.47.4.592

  5. Dlugosz, J A

    • Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes April 1998 47:668-676; doi:10.2337/diabetes.47.4.668

  6. Donahue, E P

    • Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes April 1998 47:523-529; doi:10.2337/diabetes.47.4.523

  7. Drucker, D J

    • Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes April 1998 47:632-639; doi:10.2337/diabetes.47.4.632
    • Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes April 1998 47:646-652; doi:10.2337/diabetes.47.4.646

E

  1. Ebina, Y

    • Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes April 1998 47:550-558; doi:10.2337/diabetes.47.4.550

  2. Echwald, S M

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

  3. Eckel, J

    • Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. Diabetes April 1998 47:515-522; doi:10.2337/diabetes.47.4.515

  4. Ellis, T M

    • The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes April 1998 47:566-569; doi:10.2337/diabetes.47.4.566

  5. Erickson, J C

    • Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes April 1998 47:538-543; doi:10.2337/diabetes.47.4.538

  6. Eriksson, U J

    • Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes April 1998 47:677-684; doi:10.2337/diabetes.47.4.677

F

  1. Ferrer, J

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

  2. Ferri, C

    • Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes April 1998 47:660-667; doi:10.2337/diabetes.47.4.660

  3. Flamez, D

    • Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes April 1998 47:646-652; doi:10.2337/diabetes.47.4.646

  4. Franciosa, M D

    • BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. Diabetes April 1998 47:691-695; doi:10.2337/diabetes.47.4.691

  5. Fujimoto, W Y

    • Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes April 1998 47:640-645; doi:10.2337/diabetes.47.4.640

  6. Furukawa, N

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

G

  1. Garvey, W T

    • Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects. Diabetes April 1998 47:685-687; doi:10.2337/diabetes.47.4.685

  2. Greenberg, A S

    • BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. Diabetes April 1998 47:691-695; doi:10.2337/diabetes.47.4.691

H

  1. Hagi, A

    • Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes April 1998 47:550-558; doi:10.2337/diabetes.47.4.550

  2. Halban, P A

    • Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation. Diabetes April 1998 47:559-565; doi:10.2337/diabetes.47.4.559

  3. Hales, C N

    • Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes April 1998 47:688-690; doi:10.2337/diabetes.47.4.688

  4. Hansen, J B

    • Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes April 1998 47:612-620; doi:10.2337/diabetes.47.4.612

  5. Hansen, L

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

  6. Hansen, T

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

  7. Hauner, H

    • Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. Diabetes April 1998 47:515-522; doi:10.2337/diabetes.47.4.515

  8. Hauser, S

    • Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes April 1998 47:583-591; doi:10.2337/diabetes.47.4.583

  9. Hayashi, H

    • Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes April 1998 47:550-558; doi:10.2337/diabetes.47.4.550

  10. Higashi, S

    • Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats. Diabetes April 1998 47:653-659; doi:10.2337/diabetes.47.4.653

  11. Hill, J R

    • Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes April 1998 47:583-591; doi:10.2337/diabetes.47.4.583

  12. Hitman, G A

    • Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes April 1998 47:688-690; doi:10.2337/diabetes.47.4.688

I

  1. Inoue, H

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

J

  1. Jinagouda, S D

    • Physiological insulinemia acutely modulates plasma leptin. Diabetes April 1998 47:544-549; doi:10.2337/diabetes.47.4.544

  2. Judge, M E

    • Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes April 1998 47:612-620; doi:10.2337/diabetes.47.4.612

  3. Jun, H S

    • Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes April 1998 47:576-582; doi:10.2337/diabetes.47.4.576

K

  1. Kahn, S E

    • Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes April 1998 47:640-645; doi:10.2337/diabetes.47.4.640

  2. Kamdar, V

    • Physiological insulinemia acutely modulates plasma leptin. Diabetes April 1998 47:544-549; doi:10.2337/diabetes.47.4.544

  3. Kaneko, K

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

  4. Kang, Y

    • Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes April 1998 47:576-582; doi:10.2337/diabetes.47.4.576

  5. Kapor-Drezgic, J

    • Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes April 1998 47:668-676; doi:10.2337/diabetes.47.4.668

  6. Khan, A

    • Physiological insulinemia acutely modulates plasma leptin. Diabetes April 1998 47:544-549; doi:10.2337/diabetes.47.4.544

  7. Kilpatrick, E D

    • Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line. Diabetes April 1998 47:606-611; doi:10.2337/diabetes.47.4.606

  8. Kim, K H

    • Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes April 1998 47:576-582; doi:10.2337/diabetes.47.4.576

  9. Kishi, K

    • Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes April 1998 47:550-558; doi:10.2337/diabetes.47.4.550

  10. Kishikawa, H

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

  11. Kuijper, J L

    • Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes April 1998 47:538-543; doi:10.2337/diabetes.47.4.538

  12. Kwon, G

    • Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes April 1998 47:583-591; doi:10.2337/diabetes.47.4.583

L

  1. Lan, M S

    • The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes April 1998 47:566-569; doi:10.2337/diabetes.47.4.566

  2. Larsen, P J

    • Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes April 1998 47:530-537; doi:10.2337/diabetes.47.4.530

  3. Leonetti, D L

    • Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes April 1998 47:640-645; doi:10.2337/diabetes.47.4.640

  4. Liang, L

    • The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice. Diabetes April 1998 47:570-575; doi:10.2337/diabetes.47.4.570

  5. Lien, P

    • BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. Diabetes April 1998 47:691-695; doi:10.2337/diabetes.47.4.691

  6. Likes, C E

    • Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects. Diabetes April 1998 47:685-687; doi:10.2337/diabetes.47.4.685

  7. Liu, L S

    • Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. Diabetes April 1998 47:515-522; doi:10.2337/diabetes.47.4.515

  8. Lok, S

    • Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes April 1998 47:538-543; doi:10.2337/diabetes.47.4.538

M

  1. Maclaren, N K

    • The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes April 1998 47:566-569; doi:10.2337/diabetes.47.4.566

  2. Mannan, N

    • Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes April 1998 47:688-690; doi:10.2337/diabetes.47.4.688

  3. Marshall, B A

    • Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes April 1998 47:632-639; doi:10.2337/diabetes.47.4.632

  4. Matsumoto, K

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

  5. Mazzocchi, C

    • Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes April 1998 47:660-667; doi:10.2337/diabetes.47.4.660

  6. McDaniel, M L

    • Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes April 1998 47:583-591; doi:10.2337/diabetes.47.4.583

  7. McDermott, M F

    • Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes April 1998 47:688-690; doi:10.2337/diabetes.47.4.688

  8. Menger, M D

    • Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation. Diabetes April 1998 47:559-565; doi:10.2337/diabetes.47.4.559

  9. Michael, R

    • Physiological insulinemia acutely modulates plasma leptin. Diabetes April 1998 47:544-549; doi:10.2337/diabetes.47.4.544

  10. Miyata, I

    • Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes April 1998 47:550-558; doi:10.2337/diabetes.47.4.550

  11. Miyazaki, J

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

  12. Motoshima, H

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

  13. Muromoto, N

    • Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes April 1998 47:550-558; doi:10.2337/diabetes.47.4.550

  14. Møller, A M

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

N

  1. Nakaya, Y

    • Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes April 1998 47:550-558; doi:10.2337/diabetes.47.4.550

  2. Neal, D W

    • Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes April 1998 47:523-529; doi:10.2337/diabetes.47.4.523

  3. Newell-Morris, L

    • Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes April 1998 47:640-645; doi:10.2337/diabetes.47.4.640

  4. Notkins, A L

    • The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes April 1998 47:566-569; doi:10.2337/diabetes.47.4.566
    • Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes April 1998 47:576-582; doi:10.2337/diabetes.47.4.576

O

  1. Ogunkolade, B W

    • Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes April 1998 47:688-690; doi:10.2337/diabetes.47.4.688

  2. Ottendorfer, E W

    • The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes April 1998 47:566-569; doi:10.2337/diabetes.47.4.566

P

  1. Palmiter, R D

    • Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes April 1998 47:538-543; doi:10.2337/diabetes.47.4.538

  2. Pedersen, O

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

  3. Permutt, M A

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

  4. Peterson, R

    • Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects. Diabetes April 1998 47:685-687; doi:10.2337/diabetes.47.4.685

  5. Pipeleers, D

    • Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes April 1998 47:646-652; doi:10.2337/diabetes.47.4.646

  6. Prud'homme, G J

    • The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice. Diabetes April 1998 47:570-575; doi:10.2337/diabetes.47.4.570

Q

  1. Quartier, E

    • Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes April 1998 47:646-652; doi:10.2337/diabetes.47.4.646

R

  1. Riad-Gabriel, M G

    • Physiological insulinemia acutely modulates plasma leptin. Diabetes April 1998 47:544-549; doi:10.2337/diabetes.47.4.544

  2. Rimvall, K

    • Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes April 1998 47:612-620; doi:10.2337/diabetes.47.4.612

  3. Robertson, R P

    • Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line. Diabetes April 1998 47:606-611; doi:10.2337/diabetes.47.4.606

  4. Röhrig, K

    • Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. Diabetes April 1998 47:515-522; doi:10.2337/diabetes.47.4.515

S

  1. Saad, M F

    • Physiological insulinemia acutely modulates plasma leptin. Diabetes April 1998 47:544-549; doi:10.2337/diabetes.47.4.544

  2. Salisbury, P J

    • The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes April 1998 47:566-569; doi:10.2337/diabetes.47.4.566

  3. Santucci, A

    • Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes April 1998 47:660-667; doi:10.2337/diabetes.47.4.660

  4. Schatz, D A

    • The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes April 1998 47:566-569; doi:10.2337/diabetes.47.4.566

  5. Schenker, M

    • GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes April 1998 47:592-597; doi:10.2337/diabetes.47.4.592

  6. Schuit, F

    • Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes April 1998 47:646-652; doi:10.2337/diabetes.47.4.646

  7. Schwartz, M W

    • Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes April 1998 47:538-543; doi:10.2337/diabetes.47.4.538

  8. Schwartz, R S

    • Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes April 1998 47:640-645; doi:10.2337/diabetes.47.4.640

  9. Scrocchi, L A

    • Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes April 1998 47:632-639; doi:10.2337/diabetes.47.4.632
    • Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes April 1998 47:646-652; doi:10.2337/diabetes.47.4.646

  10. Seeley, R J

    • Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes April 1998 47:538-543; doi:10.2337/diabetes.47.4.538

  11. Seidel, D

    • GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes April 1998 47:592-597; doi:10.2337/diabetes.47.4.592

  12. Sharma, A

    • Physiological insulinemia acutely modulates plasma leptin. Diabetes April 1998 47:544-549; doi:10.2337/diabetes.47.4.544

  13. Sheardown, M J

    • Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes April 1998 47:612-620; doi:10.2337/diabetes.47.4.612

  14. She, J X

    • The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes April 1998 47:566-569; doi:10.2337/diabetes.47.4.566

  15. Shichiri, M

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

  16. Shirakami, A

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

  17. Shirotani, T

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

  18. Sindelar, D K

    • Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes April 1998 47:523-529; doi:10.2337/diabetes.47.4.523

  19. Snow, A D

    • Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes April 1998 47:612-620; doi:10.2337/diabetes.47.4.612

  20. Souza, S C

    • BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. Diabetes April 1998 47:691-695; doi:10.2337/diabetes.47.4.691

  21. Spelleken, M

    • Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. Diabetes April 1998 47:515-522; doi:10.2337/diabetes.47.4.515

  22. Spiegelman, B M

    • PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes April 1998 47:507-514; doi:10.2337/diabetes.47.4.507

  23. Steil, G M

    • Physiological insulinemia acutely modulates plasma leptin. Diabetes April 1998 47:544-549; doi:10.2337/diabetes.47.4.544

T

  1. Tang-Christensen, M

    • Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes April 1998 47:530-537; doi:10.2337/diabetes.47.4.530

  2. Tsuruzoe, K

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

  3. Turk, J

    • Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes April 1998 47:583-591; doi:10.2337/diabetes.47.4.583

U

  1. Urhammer, S A

    • Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598

V

  1. Vajkoczy, P

    • Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation. Diabetes April 1998 47:559-565; doi:10.2337/diabetes.47.4.559

  2. Van Breusegem, A

    • Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes April 1998 47:646-652; doi:10.2337/diabetes.47.4.646

  3. Venson, P

    • Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes April 1998 47:523-529; doi:10.2337/diabetes.47.4.523

  4. Verchere, C B

    • Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes April 1998 47:640-645; doi:10.2337/diabetes.47.4.640

  5. Vrang, N

    • Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes April 1998 47:530-537; doi:10.2337/diabetes.47.4.530

W

  1. Wahl, P W

    • Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes April 1998 47:640-645; doi:10.2337/diabetes.47.4.640

  2. Wasserfall, C

    • The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes April 1998 47:566-569; doi:10.2337/diabetes.47.4.566

  3. Watson, D K

    • Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects. Diabetes April 1998 47:685-687; doi:10.2337/diabetes.47.4.685

  4. Weigle, D S

    • Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes April 1998 47:538-543; doi:10.2337/diabetes.47.4.538

  5. Wentzel, P

    • Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes April 1998 47:677-684; doi:10.2337/diabetes.47.4.677

  6. Whiteside, C

    • Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes April 1998 47:668-676; doi:10.2337/diabetes.47.4.668

Y

  1. Yamamoto, M T

    • BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. Diabetes April 1998 47:691-695; doi:10.2337/diabetes.47.4.691

  2. Yang, W

    • Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes April 1998 47:612-620; doi:10.2337/diabetes.47.4.612

  3. Yoon, H S

    • Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes April 1998 47:576-582; doi:10.2337/diabetes.47.4.576

  4. Yoon, J W

    • Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes April 1998 47:576-582; doi:10.2337/diabetes.47.4.576

  5. Yoshizato, K

    • Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621

Z

  1. Ziegler, A G

    • GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes April 1998 47:592-597; doi:10.2337/diabetes.47.4.592

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement